Alternative ETFs Beyond BOND: Negligible ETF Fallout After Gross Departure By Tom LydonSeptember 26, 2014
Contributed BlackRock: Your Goals Are Bigger Than a Benchmark. Your Investments Should Be, Too By iSharesSeptember 25, 2014
Featured Pfizer, Actavis Rumor, Inversion Turn Attention to Pharma ETFs By Tom LydonSeptember 24, 2014
Contributed Indexology®: Alibaba, Hedge Funds and Transparency By S&P Dow Jones IndicesSeptember 23, 2014